| Primary |
| Depression |
51.2% |
| Drug Use For Unknown Indication |
22.8% |
| Product Used For Unknown Indication |
12.3% |
| Anxiety |
3.0% |
| Major Depression |
2.1% |
| Bipolar Disorder |
1.6% |
| Hypertension |
1.0% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
| Smoking Cessation Therapy |
0.8% |
| Fibromyalgia |
0.7% |
| Osteopenia |
0.7% |
| Ill-defined Disorder |
0.4% |
| Insomnia |
0.4% |
| Pain |
0.4% |
| Complicated Migraine |
0.3% |
| Dyslipidaemia |
0.3% |
| Hormone Replacement Therapy |
0.3% |
| Mental Disorder |
0.3% |
| Affective Disorder |
0.3% |
| Ex-tobacco User |
0.3% |
|
| Drug Ineffective |
17.5% |
| Insomnia |
7.5% |
| Tremor |
7.5% |
| Rash |
6.2% |
| Tinnitus |
6.0% |
| Nausea |
5.5% |
| Vomiting |
5.1% |
| Urticaria |
4.5% |
| Suicidal Ideation |
4.0% |
| Product Quality Issue |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| Headache |
3.6% |
| Somnolence |
3.6% |
| Death |
3.4% |
| Alopecia |
3.2% |
| Feeling Abnormal |
3.2% |
| Overdose |
3.2% |
| Convulsion |
2.8% |
| Therapeutic Response Unexpected |
2.8% |
| Adverse Event |
2.6% |
|
| Secondary |
| Depression |
42.2% |
| Drug Use For Unknown Indication |
18.7% |
| Product Used For Unknown Indication |
11.0% |
| Bipolar Disorder |
9.2% |
| Major Depression |
2.2% |
| Anxiety |
2.1% |
| Insomnia |
1.9% |
| Bipolar I Disorder |
1.6% |
| Pain |
1.6% |
| Seasonal Affective Disorder |
1.4% |
| Dyspnoea |
1.3% |
| Alcoholism |
1.0% |
| Hypertension |
1.0% |
| Smoking Cessation Therapy |
1.0% |
| Diverticulitis |
0.8% |
| Affective Disorder |
0.6% |
| Asthma |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.6% |
| Diabetes Mellitus |
0.6% |
| Fibromyalgia |
0.6% |
|
| Tremor |
9.3% |
| Drug Ineffective |
8.6% |
| Rash |
7.9% |
| Weight Increased |
7.9% |
| Death |
7.1% |
| Suicidal Ideation |
5.7% |
| Insomnia |
5.0% |
| Suicide Attempt |
5.0% |
| Urticaria |
5.0% |
| Encephalopathy |
4.3% |
| Nausea |
4.3% |
| Somnolence |
4.3% |
| Weight Decreased |
4.3% |
| Completed Suicide |
3.6% |
| Depression |
3.6% |
| Lung Neoplasm Malignant |
2.9% |
| Malaise |
2.9% |
| Palpitations |
2.9% |
| Pharmaceutical Product Complaint |
2.9% |
| Smoker |
2.9% |
|
| Concomitant |
| Depression |
21.9% |
| Product Used For Unknown Indication |
11.3% |
| Drug Use For Unknown Indication |
9.0% |
| Anxiety |
8.2% |
| Pain |
7.0% |
| Bipolar Disorder |
6.6% |
| Hypertension |
5.8% |
| Insomnia |
4.5% |
| Sleep Disorder |
4.1% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Multiple Sclerosis |
2.7% |
| Diabetes Mellitus |
2.3% |
| Migraine |
2.1% |
| Asthma |
2.0% |
| Schizophrenia |
2.0% |
| Multiple Myeloma |
1.7% |
| Hormone Replacement Therapy |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Restless Legs Syndrome |
1.5% |
| Major Depression |
1.5% |
|
| Type 2 Diabetes Mellitus |
22.7% |
| Weight Increased |
17.9% |
| Vomiting |
6.0% |
| Ventricular Septal Defect |
5.4% |
| Suicidal Ideation |
5.3% |
| Weight Decreased |
4.5% |
| Suicide Attempt |
4.2% |
| Vision Blurred |
3.6% |
| Diabetes Mellitus |
2.9% |
| Pain |
2.8% |
| Pulmonary Embolism |
2.8% |
| Tremor |
2.8% |
| Drug Ineffective |
2.6% |
| Pancreatitis |
2.6% |
| Nausea |
2.5% |
| Tooth Extraction |
2.5% |
| Deep Vein Thrombosis |
2.3% |
| Somnolence |
2.3% |
| Myocardial Infarction |
2.2% |
| Rash |
2.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
35.7% |
| Depression |
21.4% |
| Hypertonic Bladder |
14.3% |
| Sjogren's Syndrome |
14.3% |
| Bipolar Disorder |
7.1% |
| Nerve Block |
7.1% |
|
| Anticonvulsant Drug Level Increased |
50.0% |
| Vomiting |
25.0% |
| Grand Mal Convulsion |
12.5% |
| Transient Ischaemic Attack |
12.5% |
|
